Target intelligence / Profile preview

Cell adhesion molecule (CAM) (CAM)

Target
CAM
Molecular classification
Receptor, Cell adhesion molecule, Glycoprotein
01

Overview

Cell adhesion molecules (CAMs) are a diverse group of cell-surface glycoproteins that mediate the physical attachment between cells or between a cell and the extracellular matrix (ECM) (Gumbiner, 1996, PubMed). They are categorized into four major families: integrins, cadherins, selectins, and the immunoglobulin superfamily (IgSF) (StatPearls, 2023). Beyond providing structural integrity, CAMs act as receptors that trigger intracellular signaling pathways regulating cell survival, proliferation, and migration (Janiszewska et al., 2020, PubMed). In pathological states, dysregulated CAM expression facilitates tumor metastasis by allowing cancer cells to detach from primary sites and adhere to distant tissues (Okegawa et al., 2004, PubMed). They also play a critical role in inflammatory diseases by mediating the recruitment and extravasation of leukocytes into tissues (Ley et al., 2007, Nature Reviews Immunology). Consequently, CAMs are significant therapeutic targets; for instance, monoclonal antibodies targeting specific integrins, such as Natalizumab and Vedolizumab, are used to treat multiple sclerosis and inflammatory bowel disease by blocking the entry of inflammatory cells into target organs (DrugBank, 2024).

Other names
Cell-surface adhesion proteinsCell adhesion moleculesCAMsAdhesion receptorsIntercellular adhesion moleculesCell-matrix adhesion proteins
02

Mechanism of action

Inhibition of cell-cell or cell-matrix adhesion by blocking the interaction between adhesion molecules and their ligands, thereby preventing leukocyte recruitment or tumor cell migration (Ley et al., 2007, Nature Reviews Immunology).

03

Biological functions

Cell-cell adhesionCell-matrix adhesionSignal transductionLeukocyte extravasationTissue morphogenesisSynaptic plasticity
04

Disease associations

CancerInflammationAutoimmune diseaseCardiovascular diseaseInfection
05

Safety considerations

Progressive multifocal leukoencephalopathy (PML)Increased risk of opportunistic infectionsHypersensitivity reactionsImpaired wound healing
06

Interacting drugs

Natalizumab

4 more in the full profile.

07

Biomarkers

Soluble ICAM-1 (sICAM-1)Soluble VCAM-1 (sVCAM-1)E-selectin expressionIntegrin alpha-4-beta-7 expression

Beyond the preview

Go deeper on Cell adhesion molecule (CAM) (CAM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell adhesion molecule (CAM) (CAM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call